In order to evaluate the utility of some novel drug classes for the treatment of TSC related tumors, we investigated the efficacy of asparaginase, sunitinib, bevacizumab, and vincristine in treating a relevant subcutaneous tumor model. The gene discussed is ASPG; the disease is tuberous sclerosis.